TMEM55B knockout (KO) mutants were generated using CRISPR/Cas9 methods35,44. Briefly, specific gRNAs were co-injected with Cas9 mRNA in the yolk of TAB5 embryos at the 1-cell stage. At 24 h post fertilization (hpf) ~32 embryos from each injection were collected, the genomic DNA was extracted using the Extract-N-Amp Tissue PCR kit (Sigma-Aldrich, XNAT2) and the target efficacy was tested using Fluorescent-PCR methods44. Only embryos from injections with high target frequency were moved into the system and grown until adulthood. The F1 generations obtained from an outcross of potential F0 founders with WT fish were screened for mutations and raised to adulthood. F1 adults were genotyped by fin amputation, the gDNA was extracted by the fin tissues and fluorescent PCRs were performed35. To determine the exact mutations in the F1 population the fluorescent PCR reactions were Sanger sequenced and the exact sequence was reconstructed by manually annotation of the electropherograms using WT sequences as reference. Double-heterozygous TMEM55B-KO fish were in-crossed and double-homozygous animals were selected by genotyping. Finally, TMEM55B-KO were incrossed and the embryos were injected with specific gRNAs targeting the TMEM55A gene to obtain the triple-KO animals. For a list of the targets used see Supplementary Table 1.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.